NSPR Earnings & Financial Statements
InspireMD, Inc.
$0.47
-$0.03(-6.36%)
40
Overall
60
Value
18
Tech
44
Quality
Market Cap
$21.77M
Volume
198.66K
52W Range
$0.46 - $2.54
Target Price
$3.33
NSPR earnings and financial statements: InspireMD, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
NSPR Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $8.98M | $7.01M | $6.21M | $5.17M | $4.50M |
| Cost of revenue | - | $5.50M | - | $4.05M | $3.74M |
| Operating income | -$49.61M | -$33.50M | -$21.14M | -$18.71M | -$14.72M |
| EBITDA | -$48.25M | -$31.67M | -$19.62M | -$18.52M | -$14.55M |
| Net income | -$48.79M | -$32.01M | -$19.92M | -$18.49M | -$14.92M |
| EPS (diluted) | $-0.76 | $-0.76 | $-0.82 | $-2.35 | $-2.03 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $69.40M | $46.81M | $47.64M | $24.65M | $39.71M |
| Total liabilities | $14.20M | $10.72M | $8.14M | $7.26M | $6.18M |
| Shareholders’ equity | $55.20M | $36.09M | $39.50M | $17.39M | $33.53M |
| Cash and equivalents | $8.94M | $18.92M | $9.64M | $4.63M | $12.00M |
| Long-term debt | $2.22M | $1.80M | $1.04M | $1.20M | $781.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$35.10M | -$21.87M | -$16.38M | -$15.54M | -$13.21M |
| Capital expenditure | -$1.65M | -$1.40M | -$381.0K | -$473.0K | -$344.0K |
| Free cash flow | -$36.77M | -$23.27M | -$16.76M | -$16.02M | -$13.55M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NSPR | $0.47 | -6.4% | 198.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |